tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
Holding NEUP?
Track your performance easily

Neuphoria Therapeutics (NEUP) Financial Statements

234 Followers

Neuphoria Therapeutics Financial Overview

Neuphoria Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.005; its P/E ratio is ―; Neuphoria Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Dec 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.25M$ 30.70M$ 33.56M$ 40.35M$ 28.94M
Total Assets$ 43.00M$ 56.31M$ 65.31M$ 67.84M$ 54.26M
Total Debt$ ―$ 614.55K$ 693.62K$ 768.94K$ 867.84K
Net Debt$ ―$ -30.08M$ -32.87M$ -39.58M$ -28.07M
Total Liabilities$ 9.86M$ 8.59M$ 8.40M$ 7.56M$ 6.67M
Stockholders Equity$ 33.15M$ 47.72M$ -173.31M$ 60.28M$ 47.60M
Cash Flow-
Free Cash Flow-$ -5.77M-$ -12.44M-
Operating Cash Flow-----
Investing Cash Flow-$ 191.10K-$ 672.44K-
Financing Cash Flow-$ 5.99M-$ 35.11M-
Currency in USD

Neuphoria Therapeutics Earnings and Revenue History

Neuphoria Therapeutics Debt to Assets

Neuphoria Therapeutics Cash Flow

Neuphoria Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis